These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35783293)

  • 1. The Impact of Proband Indication for Genetic Testing on the Uptake of Cascade Testing Among Relatives.
    Schmidlen TJ; Bristow SL; Hatchell KE; Esplin ED; Nussbaum RL; Haverfield EV
    Front Genet; 2022; 13():867226. PubMed ID: 35783293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMPACT-FH Study for Implementing Innovative Family Communication and Cascade Testing Strategies for Familial Hypercholesterolemia.
    Jones LK; Campbell-Salome G; Walters NL; Brangan A; Morgan KM; Tricou EP; Lindsey Mills ZT; McGowan MP; Gidding SS; Johns AM; Kirchner HL; Rahm AK; Sturm AC
    JACC Adv; 2024 Sep; 3(9):101198. PubMed ID: 39238848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
    Sturm AC; Truty R; Callis TE; Aguilar S; Esplin ED; Garcia S; Haverfield EV; Morales A; Nussbaum RL; Rojahn S; Vatta M; Rader DJ
    JAMA Cardiol; 2021 Aug; 6(8):902-909. PubMed ID: 34037665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovative Implementation Strategies for Familial Hypercholesterolemia Cascade Testing: The Impact of Genetic Counseling.
    Morgan KM; Campbell-Salome G; Walters NL; Betts MN; Brangan A; Johns A; Kirchner HL; Lindsey-Mills Z; McGowan MP; Tricou EP; Rahm AK; Sturm AC; Jones LK
    J Pers Med; 2024 Aug; 14(8):. PubMed ID: 39202032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cascade testing for hereditary cancer: comprehensive multigene panels identify unexpected actionable findings in relatives.
    Heald B; Pirzadeh-Miller S; Ellsworth RE; Nielsen SM; Russell EM; Beitsch P; Esplin ED; Nussbaum RL; Pineda-Alvarez DE; Kurian AW; Hampel H
    J Natl Cancer Inst; 2024 Feb; 116(2):334-337. PubMed ID: 37756683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A proof-of-concept study of cascade screening for Familial Hypercholesterolemia in the US, adapted from the Dutch model.
    McGowan MP; Cuchel M; Ahmed CD; Khera A; Weintraub WS; Wilemon KA; Ahmad Z
    Am J Prev Cardiol; 2021 Jun; 6():100170. PubMed ID: 34327496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of genetic testing and cascade screening in familial hypercholesterolemia.
    Ajufo E; deGoma EM; Raper A; Yu KD; Cuchel M; Rader DJ
    Genet Med; 2021 Sep; 23(9):1697-1704. PubMed ID: 34040191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
    Chandrasekar T; Gross L; Gomella LG; Hegarty SE; Leong JY; Giri VN
    Eur Urol Oncol; 2020 Jun; 3(3):291-297. PubMed ID: 31278035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a chatbot to increase uptake of cascade genetic testing.
    Schmidlen T; Jones CL; Campbell-Salome G; McCormick CZ; Vanenkevort E; Sturm AC
    J Genet Couns; 2022 Oct; 31(5):1219-1230. PubMed ID: 35616645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade testing after exome sequencing: Retrospective analysis of linked family data at 2 US laboratories.
    Stefka J; Streff H; Liu P; Towne M; Smith HS
    Genet Med; 2023 May; 25(5):100818. PubMed ID: 36852743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Web-Based Tool (FH Family Share) to Increase Uptake of Cascade Testing for Familial Hypercholesterolemia: Development and Evaluation.
    Bangash H; Makkawy A; Gundelach JH; Miller AA; Jacobson KA; Kullo IJ
    JMIR Hum Factors; 2022 Feb; 9(1):e32568. PubMed ID: 35166678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitated cascade testing (FaCT): a randomized controlled trial.
    Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
    Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cascade testing for elevated lipoprotein(a) in relatives of probands with familial hypercholesterolaemia and elevated lipoprotein(a).
    Chakraborty A; Pang J; Chan DC; Ellis KL; Hooper AJ; Bell DA; Burnett JR; Moses EK; Watts GF
    Atherosclerosis; 2022 May; 349():219-226. PubMed ID: 34862044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.
    Grutters LA; Christiaans I
    Fam Cancer; 2024 Jun; 23(2):155-164. PubMed ID: 38184510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Spectrum and Cascade Screening of Familial Hypercholesterolemia in Routine Clinical Setting in Hong Kong.
    Yip MK; Kwan EY; Leung JY; Lau EY; Poon WT
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38003014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Family cascade screening for equitable identification of familial hypercholesterolemia: study protocol for a hybrid effectiveness-implementation type III randomized controlled trial.
    Johnson C; Chen J; McGowan MP; Tricou E; Card M; Pettit AR; Klaiman T; Rader DJ; Volpp KG; Beidas RS
    Implement Sci; 2024 Apr; 19(1):30. PubMed ID: 38594685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Communication Chain of Genetic Risk: Analyses of Narrative Data Exploring Proband-Provider and Proband-Family Communication in Hereditary Breast and Ovarian Cancer.
    Pedrazzani C; Aceti M; Schweighoffer R; Kaiser-Grolimund A; Bürki N; Chappuis PO; Graffeo R; Monnerat C; Pagani O; Rabaglio M; Katapodi MC; Caiata-Zufferey M
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 36013197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysis.
    Jackson CL; Huschka T; Borah B; Agre K; Zordok M; Farwati M; Moriarty J; Kullo IJ
    Am J Prev Cardiol; 2021 Dec; 8():100245. PubMed ID: 34485965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.